Effect of ALS IgG on motor neurons in organotypic spinal cord cultures

Canadian Journal of Neurological Sciences

Volumn 35, Issue 2, 2008, Pages 220-225

  Li, Bin ^a   Liu, Xiao Yun ^a,b   Li, Zhe ^a   Bu, Hui ^a,b   Sun, Meng Meng ^a   Guo, Yan Su ^a,b   Li, Chun Yan ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Institute of Cardiocerebrovascular Disease   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; LACTATE DEHYDROGENASE;

ADULT; AFFINITY CHROMATOGRAPHY; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL DAMAGE; CELL SURVIVAL; CLINICAL ARTICLE; COLORIMETRY; CONTROLLED STUDY; ENZYME RELEASE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOTONEURON; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

EID: 45149095157     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100008672     Document Type: Article

References (25)

1. Appel SH, Glenn-Smith R, Alexianu M, Siklos L, Engelhardt J, Colom LV, et al. Increased intracellular calcium triggered by immune mechanisms in amyotrophic lateral sclerosis. Clin Neurosci. 1995;3(6):368-74.
2. Engelhardt JI, Appel SH. IgG reactivity in the spinal cord and motor cortex in amyotrophic lateral sclerosis. Arch Neurol. 1990;47(11):1210-6.
3. Alexianu ME, Kozovska M, Appel SH. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology. 2001;57(7):1282-9.
4. Li F, Pestronk A. Autoantibodies to GM1 ganglioside: different reactivity to GM1-liposomes in amyotrophic lateral sclerosis and lower motor neuron disorders. J Neurol Sci. 1991;104(2):209-14.
5. Smith RG, Hamilton S, Hofmann F, Schneider T, Nastainczyk W. Birnbaumer L, et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med. 1992;327(24):1721-8.
6. Kimura F, Smith RG, Delbono O, Nyormoi O, Schneider T. Nastainczyk W, et al. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit. Ann Neurol. 1994;35(2):164-71.
7. Couratier P, Yi FH, Preud'homme JL, Clavelou P, White A, Sindou P, et al. Serum autoantibodies to neurofilament proteins in sporadic amyotrophic lateral sclerosis. J Neurol Sci. 1998;154(2):137-45.
8. Yi FH, Lautrette C, Vermot-Desroches C, Bordessoule D, Couratier P, Wijdenes J, et al. In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients. J Neuroimmunol. 2000;109(2):211-20.
9. Sengun IS, Appel SH. Serum anti-Fas antibody levels in amyotrophic lateral sclerosis. J Neuroimmunol. 2003;142(1-2):137-40.
10. Engelhardt JI, Siklos L, Komuves L, Smith RG, Appel SH. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse. 1995;20(3):185-99.
11. Pullen AH, Humphreys P. Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls. J Neurol Sci. 2000;180(1-2):35-45.
12. Obal I, Siklos L, Engelhardt JI. Altered calcium in motoneurons by IgG from human motoneuron diseases. Acta Neurol Scand. 2002;106(5):282-91.
13. Pullen AH, Demestre M, Howard RS, Orrell RW. Passive transfer of purified IgG from patients with amyotrophic lateral sclerosis to mice results in degeneration of motor neurons accompanied by Ca2+ enhancement. Acta Neuropathol. 2004;107(1):35-46.
14. Smith RG, Alexianu ME, Crawford G, Nyormoi O, Stefani E, Appel SH. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc Natl Acad Sci USA. 1994;91(8):3393-7.
15. Alexianu ME, Mohamed AH, Smith RG, Colom LV, Appel SH. Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. J Neurochem. 1994;63(6):2365-8.
16. Demestre M, Pullen A, Orrell RW, Orth M. ALS-IgG-induced selective motor neurone apoptosis in rat mixed primary spinal cord cultures. J Neurochem. 2005;94(1):268-75.
17. Arsac C, Raymond C, Martin-Moutot N, Dargent B, Couraud F, Pouget J, et al. Immunoassays fail to detect antibodies against neuronal calcium channels in amyotrophic lateral sclerosis serum. Ann Neurol. 1996;40(5):695-700.
18. Drachman DB, Fishman PS, Rothstein JD, Motomura M, Lang B, Vincent A, et al. Amyotrophic lateral sclerosis. An autoimmune disease? Adv Neurol. 1995;68:59-65.
19. Nyormoi O. Proteolytic activity in amyotrophic lateral sclerosis IgG preparations. Ann Neurol. 1996;40(5):701-6.
20. Bär PR. Motor neuron disease in vitro: the use of cultured motor neurons to study amyotrophic lateral sclerosis. Eur J Pharmacol. 2000;405(1-3):285-95.
21. Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA. 1993;90(14):6591-5.
22. Drachman DB, Rothstein JD. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis. Ann Neurol. 2000;48(5):792-5.
23. Stoppini L, Buchs PA, Muller D. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods. 1991;37(2):173-82.
24. Noraberg J, Kristensen BW, Zimmer J. Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc. 1999;3(3):278-90.
25. Zhao W, Xie W, Le W, Beers DR, He Y, Henkel JS, et al. Activated microglia initiate motor neuron injury by a nitric oxide and glutamate-mediated mechanism. J Neuropathol Exp Neurol. 2004;63(9):964-77.